Le cluster Antiviral Agents (pharmacology) - Antiviral Agents (chemistry)
| 000D17 (2019) | Mohammed Albratty [Arabie saoudite] ; Karam Ahmed El-Sharkawy [Arabie saoudite] ; Hassan Ahmed Alhazmi [Arabie saoudite] | Synthesis and evaluation of some new 1,3,4-oxadiazoles bearing thiophene, thiazole, coumarin, pyridine and pyridazine derivatives as antiviral agents. |
| 001255 (2013) | Mi Kyoung Kim [Corée du Sud] ; Hyunjun Yoon ; Dale Lynn Barnard ; Youhoon Chong | Design, synthesis and antiviral activity of 2-(3-amino-4-piperazinylphenyl)chromone derivatives. |
| 001454 (2010) | Krishnan Suresh Kumar [Inde] ; Swastika Ganguly ; Ravichandran Veerasamy ; Erik De Clercq | Synthesis, antiviral activity and cytotoxicity evaluation of Schiff bases of some 2-phenyl quinazoline-4(3)H-ones. |
| 001511 (2009) | Yoon-Suk Lee [Corée du Sud] ; Sun Min Park ; Byeang Hyean Kim | Synthesis of 5-isoxazol-5-yl-2'-deoxyuridines exhibiting antiviral activity against HSV and several RNA viruses. |
| 000564 (2020) | Mirko Baglivo [Italie] ; Manuela Baronio [Italie] ; Giuseppe Natalini [Italie] ; Tommaso Beccari [Italie] ; Pietro Chiurazzi [Italie] ; Ezio Fulcheri [Italie] ; Paolo Pietro Petralia [Italie] ; Sandro Michelini [Italie] ; Giovanni Fiorentini [Italie] ; Giacinto Abele Miggiano [Italie] ; Assunta Morresi [Italie] ; Gerolamo Tonini [Italie] ; Matteo Bertelli [Italie] | Natural small molecules as inhibitors of coronavirus lipid-dependent attachment to host cells: a possible strategy for reducing SARS-COV-2 infectivity? |
| 000834 (2020) | Liying Dong [République populaire de Chine] ; Shasha Hu [République populaire de Chine] ; Jianjun Gao [République populaire de Chine] | Discovering drugs to treat coronavirus disease 2019 (COVID-19). |
| 000D74 (2019) | Ayman M S. Ahmed [Égypte] ; Reham A I. Abou-Elkhair [Égypte] ; Alaa M. El-Torky [Égypte] ; Abdalla E A. Hassan [Égypte] | 3-Trifluoromethylpyrazolones derived nucleosides: Synthesis and antiviral evaluation. |
| 001371 (2011) | S K Krishnan [Inde] ; S. Ganguly ; R. Veerasamy ; B. Jan | Synthesis, antiviral and cytotoxic investigation of 2-phenyl-3-substituted quinazolin-4(3H)-ones. |
| 001873 (2003) | Anna Oevermann [Suisse] ; Monika Engels [Suisse] ; Ursula Thomas [Suisse] ; Antonio Pellegrini [Suisse] | The antiviral activity of naturally occurring proteins and their peptide fragments after chemical modification |
| 000217 (2020) | David Cyranoski | This scientist hopes to test coronavirus drugs on animals in locked-down Wuhan. |
| 000402 (2020) | Manli Wang [République populaire de Chine] ; Ruiyuan Cao [République populaire de Chine] ; Leike Zhang [République populaire de Chine] ; Xinglou Yang [République populaire de Chine] ; Jia Liu [République populaire de Chine] ; Mingyue Xu [République populaire de Chine] ; Zhengli Shi [République populaire de Chine] ; Zhihong Hu [République populaire de Chine] ; Wu Zhong [République populaire de Chine] ; Gengfu Xiao [République populaire de Chine] | Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro |
| 000615 (2020) | Jared S. Morse [États-Unis] ; Tyler Lalonde [États-Unis] ; Shiqing Xu [États-Unis] ; Wenshe Ray Liu [États-Unis] | Learning from the Past: Possible Urgent Prevention and Treatment Options for Severe Acute Respiratory Infections Caused by 2019-nCoV. |
| 000A37 (2020) | Ewen Callaway ; David Cyranoski | China coronavirus: Six questions scientists are asking. |
| 001339 (2012) | Dirk Jochmans [Belgique] ; Pieter Leyssen ; Johan Neyts | A novel method for high-throughput screening to quantify antiviral activity against viruses that induce limited CPE. |
| 001340 (2012) | Anna-Winona Struck [Allemagne] ; Marco Axmann ; Susanne Pfefferle ; Christian Drosten ; Bernd Meyer | A hexapeptide of the receptor-binding domain of SARS corona virus spike protein blocks viral entry into host cells via the human receptor ACE2. |
| 001788 (2005) | Jason Paragas [États-Unis] ; Lawrence M. Blatt [États-Unis] ; Chris Hartmann [États-Unis] ; John W. Huggins [États-Unis] ; Tim P. Endy [États-Unis] | Interferon alfacon1 is an inhibitor of SARS-corona virus in cell-based models |
| This area was generated with Dilib version V0.6.33. |  |